Karen Santiago

Karen Santiago currently serves as the VP, Business Transformation and Integration Officer and Chief Accounting Officer at Catalent Pharma Solutions since September 2022. Prior experience includes a long tenure at Bristol-Myers Squibb from January 2003 to May 2022, where roles ranged from Senior Vice President & Corporate Controller to Executive Director positions in finance and operational oversight. Earlier career experiences include significant roles at Schering Plough, Johnson & Johnson, and EY. Education credentials include a Master of Business Administration in Finance from Rutgers University - Newark and a Bachelor of Science in Accounting from Rutgers Business School.